Novo Nordisk announces major expansion of Chartres manufacturing site in France
Novo Nordisk, a global healthcare leader, has announced a significant investment exceeding 16 billion Danish kroner (2.1 billion euros), slated to begin in 2023, to expand its existing production facility in Chartres, France. This strategic investment is aimed at enhancing the site’s capacity to meet the increasing demand for products within serious chronic diseases. Enhancing […]